0001104659-19-005605.txt : 20190204 0001104659-19-005605.hdr.sgml : 20190204 20190204183515 ACCESSION NUMBER: 0001104659-19-005605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190131 FILED AS OF DATE: 20190204 DATE AS OF CHANGE: 20190204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARPENTER CHRISTOPHER L. CENTRAL INDEX KEY: 0001746845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 19565636 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS STREET 2: 325 VASSAR ST., SUITE 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET, SUITE 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 325 VASSAR STREET, SUITE 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2019-01-31 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001746845 CARPENTER CHRISTOPHER L. C/O RUBIUS THERAPEUTICS, INC. 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 13.69 2019-01-31 4 A 0 100000 0 A 2029-01-30 Common Stock 100000 100000 D 25% of this option shall vest on January 31, 2020, then in 12 equal quarterly installments thereafter. /s/ Joanne M. Protano, Attorney-in-Fact 2019-02-04